SIGA Technologies (SIGA) Competitors $5.39 +0.17 (+3.26%) Closing price 04:00 PM EasternExtended Trading$5.28 -0.11 (-2.13%) As of 06:51 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsDividendEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock SIGA vs. VERA, IMCR, ANIP, SDGR, IDYA, AMPH, INDV, WVE, SPRY, and CALTShould you be buying SIGA Technologies stock or one of its competitors? The main competitors of SIGA Technologies include Vera Therapeutics (VERA), Immunocore (IMCR), ANI Pharmaceuticals (ANIP), Schrödinger (SDGR), IDEAYA Biosciences (IDYA), Amphastar Pharmaceuticals (AMPH), Indivior (INDV), Wave Life Sciences (WVE), ARS Pharmaceuticals (SPRY), and Calliditas Therapeutics AB (publ) (CALT). These companies are all part of the "pharmaceutical products" industry. SIGA Technologies vs. Vera Therapeutics Immunocore ANI Pharmaceuticals Schrödinger IDEAYA Biosciences Amphastar Pharmaceuticals Indivior Wave Life Sciences ARS Pharmaceuticals Calliditas Therapeutics AB (publ) Vera Therapeutics (NASDAQ:VERA) and SIGA Technologies (NASDAQ:SIGA) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, earnings, institutional ownership, media sentiment, profitability, dividends, risk, analyst recommendations and community ranking. Does the MarketBeat Community believe in VERA or SIGA? Vera Therapeutics received 36 more outperform votes than SIGA Technologies when rated by MarketBeat users. Likewise, 66.13% of users gave Vera Therapeutics an outperform vote while only 23.81% of users gave SIGA Technologies an outperform vote. CompanyUnderperformOutperformVera TherapeuticsOutperform Votes4166.13% Underperform Votes2133.87% SIGA TechnologiesOutperform Votes523.81% Underperform Votes1676.19% Is VERA or SIGA more profitable? SIGA Technologies has a net margin of 49.33% compared to Vera Therapeutics' net margin of 0.00%. SIGA Technologies' return on equity of 49.06% beat Vera Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Vera TherapeuticsN/A -50.13% -39.50% SIGA Technologies 49.33%49.06%38.72% Do analysts rate VERA or SIGA? Vera Therapeutics currently has a consensus target price of $64.67, suggesting a potential upside of 203.46%. Given Vera Therapeutics' stronger consensus rating and higher probable upside, analysts clearly believe Vera Therapeutics is more favorable than SIGA Technologies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Vera Therapeutics 0 Sell rating(s) 1 Hold rating(s) 6 Buy rating(s) 3 Strong Buy rating(s) 3.20SIGA Technologies 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Do insiders and institutionals have more ownership in VERA or SIGA? 99.2% of Vera Therapeutics shares are owned by institutional investors. Comparatively, 55.4% of SIGA Technologies shares are owned by institutional investors. 21.7% of Vera Therapeutics shares are owned by company insiders. Comparatively, 1.5% of SIGA Technologies shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Does the media favor VERA or SIGA? In the previous week, Vera Therapeutics and Vera Therapeutics both had 9 articles in the media. SIGA Technologies' average media sentiment score of 1.31 beat Vera Therapeutics' score of 0.81 indicating that SIGA Technologies is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Vera Therapeutics 5 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive SIGA Technologies 4 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has preferable earnings and valuation, VERA or SIGA? SIGA Technologies has higher revenue and earnings than Vera Therapeutics. Vera Therapeutics is trading at a lower price-to-earnings ratio than SIGA Technologies, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioVera TherapeuticsN/AN/A-$95.99M-$2.75-7.75SIGA Technologies$138.72M2.78$68.07M$0.826.57 Which has more risk & volatility, VERA or SIGA? Vera Therapeutics has a beta of 1.17, suggesting that its stock price is 17% more volatile than the S&P 500. Comparatively, SIGA Technologies has a beta of 0.98, suggesting that its stock price is 2% less volatile than the S&P 500. SummaryVera Therapeutics beats SIGA Technologies on 9 of the 17 factors compared between the two stocks. Remove Ads Get SIGA Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for SIGA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SIGA vs. The Competition Export to ExcelMetricSIGA TechnologiesPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$385.05M$6.32B$5.24B$7.07BDividend YieldN/A2.85%4.87%4.05%P/E Ratio4.496.7221.1817.48Price / Sales2.78186.92356.3585.27Price / Cash6.3465.6738.1634.64Price / Book1.955.576.233.79Net Income$68.07M$141.67M$3.20B$247.10M7 Day Performance-2.88%-11.43%-8.32%-7.32%1 Month Performance-0.74%-14.59%-3.36%-10.19%1 Year Performance-39.91%-18.30%2.72%-7.41% SIGA Technologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SIGASIGA Technologies2.5474 of 5 stars$5.39+3.3%N/A-47.3%$385.05M$138.72M4.4940Options VolumeNews CoveragePositive NewsGap DownVERAVera Therapeutics2.8832 of 5 stars$24.02-9.8%$64.67+169.2%-42.6%$1.53BN/A-9.2040News CoverageGap DownHigh Trading VolumeIMCRImmunocore1.7759 of 5 stars$29.67+0.3%$65.64+121.2%-54.4%$1.48B$310.20M-31.23320Positive NewsGap DownANIPANI Pharmaceuticals3.4545 of 5 stars$66.95-1.0%$79.75+19.1%+1.6%$1.46B$614.38M-121.73600Positive NewsSDGRSchrödinger1.8428 of 5 stars$19.74-1.1%$32.29+63.6%-24.2%$1.44B$207.54M-8.44790Gap DownIDYAIDEAYA Biosciences3.1971 of 5 stars$16.38-3.9%$53.58+227.1%-63.1%$1.43B$7M-4.9680News CoverageGap DownHigh Trading VolumeAMPHAmphastar Pharmaceuticals4.0936 of 5 stars$28.99+2.0%$43.50+50.1%-35.1%$1.38B$731.97M9.661,620INDVIndivior3.3027 of 5 stars$9.53-0.3%$15.00+57.4%-57.4%$1.31B$1.19B-27.231,164Positive NewsGap DownWVEWave Life Sciences4.5005 of 5 stars$8.08-6.3%$22.60+179.7%+11.8%$1.24B$108.30M-7.28240High Trading VolumeSPRYARS Pharmaceuticals3.0206 of 5 stars$12.58+0.7%$31.00+146.4%+42.6%$1.23B$89.15M-24.6790Gap DownCALTCalliditas Therapeutics AB (publ)N/A$40.00flat$39.25-1.9%N/A$1.19B$1.60B-21.62180 Remove Ads Related Companies and Tools Related Companies Vera Therapeutics Alternatives Immunocore Alternatives ANI Pharmaceuticals Alternatives Schrödinger Alternatives IDEAYA Biosciences Alternatives Amphastar Pharmaceuticals Alternatives Indivior Alternatives Wave Life Sciences Alternatives ARS Pharmaceuticals Alternatives Calliditas Therapeutics AB (publ) Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SIGA) was last updated on 4/4/2025 by MarketBeat.com Staff From Our PartnersThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredFeds Just Admitted It—They Can Take Your CashThe Government Just Said Your Money Isn't Yours That's right—According to the DOJ, YOUR hard-earned money i...Priority Gold | SponsoredCaught on Camera: Elon Musk’s “Area 51”You won’t believe what tech legend Jeff Brown found in what he calls Elon Musk’s “Area 51.” (Click here to see...Brownstone Research | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredTrump Makes Major Crypto AnnouncementTrump Ends the “War on Crypto” I expect it to pump the market, which is why I'm recommending ONE coin to al...Crypto 101 Media | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredWall St. Icon: Looming Financial Tsunami Could Wipe Out the 1%Wall Street icon who forecasted Black Monday and dot-com crash says a new economic event could hit the America...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SIGA Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share SIGA Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.